Business
– Given Imaging Ltd.(Nasdaq: GIVN; TASE: GIVN) a gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)...
Hi, what are you looking for?
– Given Imaging Ltd.(Nasdaq: GIVN; TASE: GIVN) a gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)...
– Results from Final Phase III Study of in Patients with Major Depression Associated with Bipolar I Disorder failed to show that it was...
Sealantis Ltd., a private start-up, from the Technion-Israel Institute of Technology that develops alga-mimetic tissue adhesives, reports that it has received the CE Mark...
– The Chinese company will invest $4 million in CollPlant in exchange for an allotment of shares and the commercialization of its products in...
– PillCam SB 3 will be available in the U.S. beginning in Q4 2013. The PillCam Capsule is about the size of a vitamin and allows for non-invasive viewing...
– – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic equivalent to Temodar (temozolomide)....
– The company has failed to find a partner for the further development and commercialization of its lead product, BC-819. – – Biocancell...
– This approval provides the regulatory framework for the commercialization of Lonquex in all 28 EU countries. – Illustration Teva Pharmaceutical Industries Ltd...
– Sales of the urinary tract stent will begin in 2016, subject to obtaining permits from the China Food and Drug Administration. – –...
– Compugen and Bayer will collaborate on development and commercialization of antibody-based cancer immunotherapies. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen – /By Ilan...